Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.2K Buy
8,341
+481
+6% +$2.91K ﹤0.01% 2320
2026
Q1
$47.9K Buy
7,860
+178
+2% +$978 ﹤0.01% 2206
2025
Q4
$36.6K Buy
7,682
+40
+0.5% +$193 ﹤0.01% 2277
2025
Q3
$36.9K Sell
7,642
-1,877
-20% -$7.9K ﹤0.01% 2181
2025
Q2
$40.6K Buy
9,519
+2,846
+43% +$11K ﹤0.01% 2060
2025
Q1
$23.1K Buy
6,673
+3,507
+111% +$11.2K ﹤0.01% 2302
2024
Q4
$8.8K Buy
3,166
+1,810
+133% +$5.52K ﹤0.01% 2676
2024
Q3
$4.35K Buy
1,356
+325
+32% +$1.04K ﹤0.01% 2801
2024
Q2
$2.69K Buy
1,031
+500
+94% +$1.46K ﹤0.01% 2795
2024
Q1
$1.73K Sell
531
-237
-31% -$723 ﹤0.01% 2787
2023
Q4
$2.37K Buy
+768
New +$1.95K ﹤0.01% 2523

Other funds holding SBS

GAMMA Investing's SBS Position: Q2 2026 in Review

GAMMA Investing increased its Sabesp (SBS) stake by 6.1% in Q2 2026, buying an estimated $2.91K and bringing the position to 8,341 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

GAMMA Investing first reported a position in SBS in Q4 2023 and has held it in 11 quarters since. 296 funds tracked by Wall St. Rank hold SBS as of Q2 2026.

  • GAMMA Investing held 8,341 shares of Sabesp worth $48.2K as of Q2 2026.
  • GAMMA Investing bought 481 Sabesp shares in Q2 2026, an estimated $2.91K.
  • Sabesp made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2320 holding.
  • GAMMA Investing first reported a position in Sabesp in Q4 2023 and has held it in 11 quarters since.
  • 296 funds tracked by Wall St. Rank held Sabesp as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.